NEW YORK, March 16, 2018 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) of the April 16, 2018 deadline to seek the role of lead plaintiff in a federal securities…